Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06855 ASCENTAGE-B > Detailed Quotes

06855 ASCENTAGE-B

11.840
-0.340-2.79%
Market Close 09/30 16:08 CCT
High
12.080
Open
12.000
Turnover
3.87M
Low
11.620
Pre Close
12.180
Volume
325.81K
Market Cap
3.13B
P/E(TTM)
Loss
52wk High
38.000
Shares
263.96M
P/E(Static)
Loss
52wk Low
11.160
Float Cap
3.13B
Bid/Ask %
-5.22%
Historical High
58.200
Shs Float
263.96M
Volume Ratio
0.54
Historical Low
11.160
Dividend TTM
--
Div Yield TTM
--
P/B
3.05
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.12%
Amplitude
3.78%
Avg Price
11.882
Lot Size
100
Float Cap
3.13B
Bid/Ask %
-5.22%
Historical High
58.200
Shs Float
263.96M
Volume Ratio
0.54
Historical Low
11.160
Dividend TTM
--
P/B
3.05
Dividend LFY
--
Turnover Ratio
0.12%
Amplitude
3.78%
Avg Price
11.882
Lot Size
100
Price Forecast

No Data

News

Comment

Company Overview More
Yasheng Pharmaceutical Group is an investment holding company mainly engaged in the development of innovative microtreatments for cancer, hepatitis B virus and a number of aging-related diseases. The company has a self-developed protein-protein interaction targeting drug design platform. The company's main products include the next generation kinase inhibitor HQP1351, apoptosis targeting drugs APG-1252, APG2575, APG-115 and so on. The company operates in the domestic market and overseas markets such as the United States.
CEO: Dajun Yang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...